Notice 11 Apr 2025 sec, reporting, investment, regulation, financial, compliance, finra, securities

📈FINRA Proposes Rule 6152 for Order Execution Report Disclosure

The SEC announces FINRA's proposed Rule 6152, mandating members to submit order execution information for NMS stocks to FINRA for centralized publication. This initiative aims to improve transparency, allowing investors and market participants better access to execution quality data, promoting informed investment decisions across the financial industry.

Learn More
Notice 28 Feb 2025 securities, regulation, reporting, national exchanges, compliance, sec

📈SEC Requests OMB Review on Rule 6a-3 Compliance Requirements

The Securities and Exchange Commission issued a notice regarding the extension of Rule 6a-3 under the Securities Exchange Act. This rule mandates national securities exchanges to report essential data and communications aimed at ensuring compliance and oversight. The notice invites public comments on the information collection process and emphasizes its necessity for effective regulatory functions.

Learn More
Compliance, Regulatory Requirements 28 Jan 2025 reporting, regulation, transportation, compliance, service quality, airline

✈️DOT Notice on Airline Service Quality Information Collection

In accordance with the Paperwork Reduction Act of 1995, this notice announces DOT's intention to renew Office of Management and Budget (OMB) Control Number 2138-0041 covering Airline Service Quality Performance On-time Performance and Mishandled Baggage reports that the largest U.S. air carriers file with DOT.

Learn More
Regulatory Requirements, Compliance 17 Jan 2025 regulatory compliance, healthcare, reporting, fda, adverse events, food and drug, submission guidelines

📋FDA Adverse Event Reporting

The Food and Drug Administration (FDA, the Agency, or we) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on information collection associated with FDA's adverse event reports and product experience reports for FDA-regulated products.

Learn More
Compliance, Financial 15 Jan 2025 compliance, sec, securities, reporting, employee benefits, financial regulation
Reporting, Regulatory 3 Jan 2025 federal employees, compliance, foreign governments, reporting, gifts